Health Care/Hospital

Global Health Leaders Convene in Kuala Lumpur from 25-27 November for Malaysia International Healthcare Megatrends 2025

A Major Conference on Innovation, Digital Health and Sustainable Care Systems KUALA LUMPUR, Malaysia, Nov. 22, 2025 /PRNewswire/ -- Healthcare leaders, policymakers and innovators from around the world will convene inMalaysia next week for the Malaysia International Healthcare (MIH) Megatrends 20...

2025-11-22 02:05 3560

From Vietnam to Italy to the Middle East: Better by MTA Expands Platinum Network of Global Healthcare Excellence

PALM BEACH GARDENS, Fla., Nov. 22, 2025 /PRNewswire/ -- Better by MTA, the premier medical tourism platform dedicated to promoting transparency, access, and high quality in global healthcare, is proud to announce that three distinguished institutions have joined its network as Platinum Members:Vi...

2025-11-22 00:15 1936

Gerontech and Innovation Expo cum Summit 2025 20 to 23 November: Showcasing nearly 1000 innovative technology products and solutions to co-create smart ageing future

HONG KONG, Nov. 21, 2025 /PRNewswire/ -- The 9th Gerontech and Innovation Expo cum Summit (GIES), co-organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Council of Social Service (HKCSS), and co-hosted by the Hong Kong Science and Technology Parks Corpora...

2025-11-21 22:58 2277

BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC

* Celebrating a Shared Milestone: BioDlink and Lepu Biopharma celebrated the launch of MEIYOUHENG®, the world's first EGFR-Targeting ADC, and their partnership spanning over two years. * Demonstrating Robust Capabilities: Throughout the collaboration, all technology transfers and GMP manufact...

2025-11-21 21:00 1292

K-Beauty & K-MediTech Expo Malaysia 2025 Opens to Strong Turnout, Accelerating Cross-Industry Growth in Southeast Asia

PENANG, Malaysia, Nov. 21, 2025 /PRNewswire/ -- K-Beauty Expo Malaysia 2025 and K-MediTech Expo Malaysia 2025, organized by KINTEX, officially opened today at the Penang Waterfront Convention Centre (PWCC), marking a significant milestone as two of Korea's most recognised industry exhibitions deb...

2025-11-21 17:30 1320

Sisram Medical Launches Universkin by Alma in Hong Kong, Pioneering a New Era of AI-assisted Personalized Skincare

HONG KONG, Nov. 21, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group offering Energy-Based Devices (EBD), injectables, and other complementary solutions, announced...

2025-11-21 16:15 1001

Hong Kong hosts landmark International Genomic Medicine Symposium

300 Industry Leaders Gather to Drive Medical Innovations and Showcase Hong Kong's Strengths HONG KONG, Nov. 21, 2025 /PRNewswire/ -- The International Genomic Medicine Symposium (Symposium), jointly organised by the Hong Kong Genome Institute (HKGI), Rare Diseases International (RDI), and The La...

2025-11-21 15:49 759

Telix Opens TMS Yokohama in Japan, Commemorative Lecture Held

MELBOURNE, Australia and KYOTO, Japan, Nov. 21, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the official opening of Telix Manufacturing Solutions (TMS) inYokohama, Japan, the Company's first cyclotron facility in theAsia Pacific region (APAC...

2025-11-21 14:22 3010

NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

* Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 Program * The ability to attract seasoned ophthalmology leaders highlights the compelling opportunity ...

2025-11-21 13:46 980

Everest Medicines Announces First Patient Dosed in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14

* The first patient had received the first dose of EVM14 injection in a global, multi-center Phase I clinical trial of Everest Medicines' Tumor-Associated Antigen (TAA) Cancer Vaccine EVM14 at NEXT Oncology Virginia in the United States, marking an important milestone in its global clinical dev...

2025-11-21 12:01 1012

National Cancer Institute Broadens Partnership with Medidata to Bring Unmatched Continuity of Medical and Clinical Data for Lead Protocol Organizations

The Medidata Data Experience offering will enable the National Cancer Institute Lead Protocol Organizations to expedite the development of life-saving medicines for patients SINGAPORE, Nov. 21, 2025 /PRNewswire/ -- Medidata , a Dassault Systèmes brand and leading provi...

2025-11-21 11:28 851

Dimora Medical Reaffirms Long-Term Commitment to Pressure Injury Patients on Worldwide Pressure Injury Prevention Day

NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Observed annually on the third Thursday of November each year, Worldwide Pressure Injury Prevention Day serves as a global reminder of the urgent need to prevent pressure injuries, also known as pressure ulcers or bedsores, among vulnerable populations. Est...

2025-11-21 11:14 667

Colebrook Bosson Saunders Launches Their First Sustainability Report

HONG KONG, Nov. 21, 2025 /PRNewswire/ -- As the world turns its attention to the environment duringCOP30, Colebrook Bosson Saunders (CBS),  the leader in workplace ergonomics, is underscorin...

2025-11-21 09:00 923

PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting

IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1 studies of PMB-CT01 (BAFFR-CAR T) have been accepted fo...

2025-11-20 23:12 1324

HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases

* Company enters into new agreement with the Gates Foundation to identify novel drug leads targeting tuberculosis and malaria and new agents for non-hormonal contraception. CHENGDU, China, Nov. 20, 2025 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH...

2025-11-20 22:30 871

ReviR Therapeutics Receives $4.6 Million CIRM Grant to Advance Huntington's Disease Treatment and Announces Key Development Milestone

BRISBANE, Calif., Nov. 20, 2025 /PRNewswire/ -- ReviR Therapeutics, a biotech company focused on developing innovative treatments for neurogenetic diseases, announced today that it has been awarded a$4.6M grant from the California Institute for Regenerative Medicine (CIRM)

2025-11-20 22:00 772

GENPRIME ACCELERATES GLOBAL GROWTH WITH FERTILITY CENTRE LAUNCHES IN SINGAPORE AND MANILA

The Singapore and New York-headquartered network of clinics expands its Southeast Asia presence, addressing global family-building challenges with technology and empathy NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Rhea Fertility, the reproductive health platform headquartered inSingapore and New Yor...

2025-11-20 22:00 850

Kolmar Korea Named Among TIME's World's Best Companies in Sustainable Growth 2026 for the Second Consecutive Year

Ranked in the Top 7% Among More Than 4,000 Global Corporations, Highlighting Leadership in Eco-Friendly Innovation and Responsible Growth SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Kolmar Korea , a global cosmetics ODM leader, has been selected for the secon...

2025-11-20 21:30 1575

Henlius' Serplulimab (anti-PD-1 mAb) Granted Breakthrough Therapy Designation by China NMPA for Neo-/Adjuvant Treatment for Gastric Cancer

* The first CDE-designated Breakthrough Therapy for perioperative gastric cancer, promising accelerated patient access. * The world's first gastric cancer perioperative regimen replacing chemotherapy with immunotherapy alone in the adjuvant setting has met primary endpoints in its phase 3 cli...

2025-11-20 18:52 1195

Clarity Eye Centre Brings SILK™ Laser Eye Technology to Hong Kong

HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Clarity Eye Centre announced the arrival of Johnson & Johnson's next-generation SILK™ Laser Eye Technology, now available to patients inHong Kong. The clinic is the first in the city to widely offer the ELITA™ Femtosecond Laser, the advanced system that po...

2025-11-20 17:34 1135
1 ... 78910111213 ... 860